Xuefei T. Guo

Beijing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 36 publications

Risk Stratification and Clinical Outcomes for Surgically Treated Brain Metastasis: A Single Institutional Experience from China.

Risk Stratification and Clinical Outcomes for Surgically Treated Brain Metastasis: A Single Institutional Experience from China.

Journal: World neurosurgery

Published: June 16, 2026

Uncoupling Type I Interferon Benefits From Inflammatory Toxicity: Transformer-Prioritized Precision Agonists for Potent and Safer Cancer Immunotherapy.

Uncoupling Type I Interferon Benefits From Inflammatory Toxicity: Transformer-Prioritized Precision Agonists for Potent and Safer Cancer Immunotherapy.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: March 12, 2026

Structural insights into human signal peptide peptidase.

Structural insights into human signal peptide peptidase.

Journal: Proceedings of the National Academy of Sciences of the United States of America

Published: December 17, 2025

c-Met inhibitor NVP-BVU972 induces antiviral protection and suppresses NF-κB-mediated inflammation.

c-Met inhibitor NVP-BVU972 induces antiviral protection and suppresses NF-κB-mediated inflammation.

Journal: Frontiers in immunology

Published: June 22, 2025

Betrixaban activates cGAS and ERVs to promote dual nucleic-sensing antiviral immunity.

Betrixaban activates cGAS and ERVs to promote dual nucleic-sensing antiviral immunity.

Journal: EMBO molecular medicine

Published: May 27, 2025

LMNA R527C pathogenic variant causes an inflammation-driven segmental progeroid syndrome via triggering DNA-sensing pathways.

LMNA R527C pathogenic variant causes an inflammation-driven segmental progeroid syndrome via triggering DNA-sensing pathways.

Journal: Protein & cell

Published: May 23, 2025

Betrixaban is a broad anti-virus inhibitor by activating innate immunity.

Betrixaban is a broad anti-virus inhibitor by activating innate immunity.

Journal: Frontiers in cellular and infection microbiology

Published: March 31, 2025

Engineering a Lipid Nanoparticle with Atypical Calcium Crystal Structure for Enhanced IFNβ-Mediated Immunotherapy.

Engineering a Lipid Nanoparticle with Atypical Calcium Crystal Structure for Enhanced IFNβ-Mediated Immunotherapy.

Journal: Advanced materials (Deerfield Beach, Fla.)

Published: December 17, 2024

VDLIN: A Deep Learning-Based Platform for Methylcobalamin-Inspired Immunomodulatory Compound Screening.

VDLIN: A Deep Learning-Based Platform for Methylcobalamin-Inspired Immunomodulatory Compound Screening.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: October 27, 2024

Inhibitors supercharge kinase turnover through native proteolytic circuits.

Inhibitors supercharge kinase turnover through native proteolytic circuits.

Journal: Nature

Published: July 15, 2024

Molecular mechanism of substrate recognition and cleavage by human γ-secretase.

Molecular mechanism of substrate recognition and cleavage by human γ-secretase.

Journal: Science (New York, N.Y.)

Published: June 06, 2024

Structural basis of human γ-secretase inhibition by anticancer clinical compounds.

Structural basis of human γ-secretase inhibition by anticancer clinical compounds.

Journal: Nature structural & molecular biology

Published: February 17, 2024

Showing 1-12 of 36

Last Updated: 09/26/2026